Nehal Singh, an experienced bioengineer with a strong focus in immunology and immunotherapeutics, has extensive experience working both in industry and academia over the years. In her industrial roles, Nehal has successfully characterized numerous vaccine drug products using techniques such as ELISA and bDNA during pre-clinical manufacturing. On the academic side, she worked on translating research findings from murine models to humans, specifically by the functional and phenotypical characterization of B cells that produce anti-HMGB1 IgM antibodies for autoimmune therapeutics. Alongside her scientific work, she actively volunteered, organized, and led various social groups.